Using "outbreak science" to strengthen the use of models during epidemics

Caitlin Rivers¹, Jean-Paul Chretien², Steven Riley³, Julie A Pavlin⁴, Alexandra Woodward^{5

6}, David Brett-Major⁷, Irina Maljkovic Berry⁸, Lindsay Morton^{5

6

9}, Richard G Jarman⁸, Matthew Biggerstaff¹⁰, Michael A Johansson¹¹, Nicholas G Reich¹², Diane Meyer¹³, Michael R Snyder¹³, Simon Pollett^{7

8

14}

Affiliations

¹ Johns Hopkins Center for Health Security, Baltimore, MD, 21202, USA. crivers6@jhu.edu.
² Department of Defense, Fort Detrick, MD, 21702, USA.
³ MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College, London, UK.
⁴ National Academies of Sciences, Engineering, and Medicine, Washington, DC, 20006, USA.
⁵ Cherokee Nation Strategic Programs, Tulsa, OK, 74116, USA.
⁶ Global Emerging Infections Surveillance, Armed Forces Health Surveillance Branch, Silver Spring, MD, 20904, USA.
⁷ Department of Preventive Medicine & Biostatistics, Uniformed Services University, Bethesda, MD, 20814, USA.
⁸ Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
⁹ Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, 20037, USA.
¹⁰ Influenza Division, Centers for Disease Control & Prevention, Atlanta, GA, 30333, USA.
¹¹ Division of Vector-Borne Diseases, Centers for Disease Control & Prevention, Atlanta, PR, USA.
¹² Department of Biostatistics and Epidemiology, University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, 01003, USA.
¹³ Johns Hopkins Center for Health Security, Baltimore, MD, 21202, USA.
¹⁴ Marie Bashir Institute for Infectious Diseases & Biosecurity, University of Sydney, Sydney, NSW, Australia.

PMID: 31308372
PMCID: PMC6629683
DOI: 10.1038/s41467-019-11067-2

Using "outbreak science" to strengthen the use of models during epidemics

Caitlin Rivers et al. Nat Commun. 2019.

. 2019 Jul 15;10(1):3102.

doi: 10.1038/s41467-019-11067-2.

Authors

Affiliations

¹ Johns Hopkins Center for Health Security, Baltimore, MD, 21202, USA. crivers6@jhu.edu.
² Department of Defense, Fort Detrick, MD, 21702, USA.
³ MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College, London, UK.
⁴ National Academies of Sciences, Engineering, and Medicine, Washington, DC, 20006, USA.
⁵ Cherokee Nation Strategic Programs, Tulsa, OK, 74116, USA.
⁶ Global Emerging Infections Surveillance, Armed Forces Health Surveillance Branch, Silver Spring, MD, 20904, USA.
⁷ Department of Preventive Medicine & Biostatistics, Uniformed Services University, Bethesda, MD, 20814, USA.
⁸ Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
⁹ Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, 20037, USA.
¹⁰ Influenza Division, Centers for Disease Control & Prevention, Atlanta, GA, 30333, USA.
¹¹ Division of Vector-Borne Diseases, Centers for Disease Control & Prevention, Atlanta, PR, USA.
¹² Department of Biostatistics and Epidemiology, University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, 01003, USA.
¹³ Johns Hopkins Center for Health Security, Baltimore, MD, 21202, USA.
¹⁴ Marie Bashir Institute for Infectious Diseases & Biosecurity, University of Sydney, Sydney, NSW, Australia.

PMID: 31308372
PMCID: PMC6629683
DOI: 10.1038/s41467-019-11067-2

Abstract

Infectious disease modeling has played a prominent role in recent outbreaks, yet integrating these analyses into public health decision-making has been challenging. We recommend establishing ‘outbreak science’ as an inter-disciplinary field to improve applied epidemic modeling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

1. Nkengasong JN, Onyebujoh P. Response to the Ebola virus disease outbreak in the Democratic Republic of the Congo. Lancet. 2018;391:2395–2398. doi: 10.1016/S0140-6736(18)31326-6. - DOI - PMC - PubMed
1. Bellan SE, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. LANCET Infect. Dis. 2015;15:703–710. doi: 10.1016/S1473-3099(15)70139-8. - DOI - PMC - PubMed
1. Gani R, et al. Potential Impact of Antiviral Drug Use during Influenza Pandemic. Emerg. Infect. Dis. 2005;11:1355–1362. doi: 10.3201/eid1209.041344. - DOI - PMC - PubMed
1. Ebola Response WHO. Team. Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections. N. Engl. J. Med. 2014;371:1481–1495. doi: 10.1056/NEJMoa1411100. - DOI - PMC - PubMed
1. Meltzer, M. et al. Estimating the Future Number of Cases in the Ebola Epidemic — Liberia and Sierra Leone, 2014–2015. MMWR Surveill Summ. 63, pp. 1–14, (2014). - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Using "outbreak science" to strengthen the use of models during epidemics

Affiliations

Using "outbreak science" to strengthen the use of models during epidemics

Authors

Affiliations

Abstract

Conflict of interest statement

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources